Apple must pay an additional $184 million in interest to healthcare company Masimo, a U.S. district court ruled, adding the amount to an original $634 million award for patent infringement related to blood oxygenation measurements in Apple WatchThe total amount that the apple giant must pay has thus risen to approximately $818,5 million.
Gallery
The court rejected the arguments Applu and request Masima
The judge dismissed the argument in his decision Applu that granting interest would constitute unjust enrichment for Masimo. Citing guidance from the US Supreme Court, he stated that interest on royalties owed serves purely to properly compensate the patent owner.
On the other hand, the court did not fully satisfy the plaintiff's demands. Masimo originally requested that interest be calculated at the California rate of 7%, which the judge rejected. Instead, he chose a rate corresponding to Masimo's actual debt costs, and despite this reduction, the annual interest rate increased the total amount owed by the aforementioned $184 million.
You might be interested in
This verdict is the latest in a protracted legal battle that has even resulted in a ban on the sale of models in the past. Apple Watch Series 9 and Ultra 2 in the US market due to a decision by the International Trade Commission (ITC). Apple was forced to modify and disable the pulse oximeter function in order to continue to safely sell its smartwatches in the US. It happens quite often that Apple sits on the defendant's bench. In this case, it is a relatively big loss.
